Jay S. Steingrub
Impact in
-
- Intensive Care Unit Cognitive Disorders
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 30
- COVID-19 Clinical Research Studies 15
- Epidemiology 43
- Sepsis Diagnosis and Treatment 22
- Influenza Virus Research Studies 14
- Respiratory viral infections research 9
- Co-authors
- Peter K. Lindenauer (20 shared papers)Tara C. Lagu (15 shared papers)Michael B. Rothberg (11 shared papers)Penelope S. Pekow (13 shared papers)Daniel Teres (11 shared papers)Meng‐Shiou Shieh (4 shared papers)Bruce Thompson (5 shared papers)Peter Rock (2 shared papers)
- Journals
- Critical Care Medicine (26 papers)MMWR Morbidity and Mortality Weekly Report (19 papers)Clinical Infectious Diseases (13 papers)JAMA (8 papers)JAMA Network Open (7 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Jay S. Steingrub
154 papers receiving 10.1k citations
Jay S. Steingrub's Hit Papers
Peers
Comparison fields: 5 of 163
- Critical Care and Intensive Care Medicine 1.0k
- Infectious Diseases 2.8k
- Modeling and Simulation 423
- Neurology 1.3k
- Health 615
Countries citing papers authored by Jay S. Steingrub
This map shows the geographic impact of Jay S. Steingrub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay S. Steingrub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay S. Steingrub more than expected).
Fields of papers citing papers by Jay S. Steingrub
This network shows the impact of papers produced by Jay S. Steingrub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay S. Steingrub. The network helps show where Jay S. Steingrub may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay S. Steingrub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020 Hit paper breakdown → | 2020 | 963 |
| 2 | Initial Trophic vs Full Enteral Feeding in Patients With Acute Lung Injury: The EDEN Randomized Trial Hit paper breakdown → | 2012 | 719 |
| 3 | Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* Hit paper breakdown → | 2004 | 704 |
| 4 | Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007 Hit paper breakdown → | 2011 | 551 |
| 5 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study Hit paper breakdown → | 2022 | 483 |
| 6 | Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity Hit paper breakdown → | 2021 | 473 |
| 7 | Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 Hit paper breakdown → | 2021 | 330 |
| 8 | 2020 | 317 | |
| 9 | 2011 | 287 | |
| 10 | 1985 | 282 | |
| 11 | Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 Hit paper breakdown → | 2021 | 223 |
| 12 | Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis Hit paper breakdown → | 2021 | 206 |
| 13 | 2003 | 180 | |
| 14 | 2008 | 174 | |
| 15 | 2020 | 165 | |
| 16 | 2020 | 162 | |
| 17 | 2021 | 157 | |
| 18 | 2020 | 153 | |
| 19 | 2013 | 143 | |
| 20 | 2019 | 143 |
About Jay S. Steingrub
Jay S. Steingrub is a scholar working on Infectious Diseases, Epidemiology, Health, Pulmonary and Respiratory Medicine and Radiological and Ultrasound Technology, having authored 154 papers that have together received 10.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (30 papers), Sepsis Diagnosis and Treatment (22 papers), COVID-19 Clinical Research Studies (15 papers), Influenza Virus Research Studies (14 papers), Respiratory Support and Mechanisms (14 papers), Vaccine Coverage and Hesitancy (12 papers), Respiratory viral infections research (9 papers) and Hemodynamic Monitoring and Therapy (8 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (1.0k citations), Infectious Diseases (2.8k citations), Modeling and Simulation (423 citations), Neurology (1.3k citations) and Health (615 citations). Jay S. Steingrub has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Peter K. Lindenauer, Tara C. Lagu, Michael B. Rothberg, Penelope S. Pekow, Daniel Teres, Meng‐Shiou Shieh, Bruce Thompson, Peter Rock, Stanley A. Lemeshow and Alan H. Morris. Their work appears in journals such as Critical Care Medicine, MMWR Morbidity and Mortality Weekly Report, Clinical Infectious Diseases, JAMA and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.